Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physicians
Despite awareness of MASLD risk factors among Canadian PCPs, substantial gaps remain in screening due to limited knowledge, inconsistent tool use, and systemic barriers. These findings highlight the need for a coordinated national strategy to support PCPs in the early identification and referral of patients at risk for MASLD-related fibrosis.
Authors
- Sahar Saeed (ORCID: https://orcid.org/0000-0002-0224-379X)
- Hsiao-Ming Jung
- Duy A Dinh (ORCID: https://orcid.org/0000-0003-0488-1143)
- James W. Kim (ORCID: https://orcid.org/0000-0002-9097-337X)
- Mark G. Swain (ORCID: https://orcid.org/0000-0002-0919-4468)
- Kenneth Cusi (ORCID: https://orcid.org/0000-0002-8629-418X)
- Jeffrey V. Lazarus (ORCID: https://orcid.org/0000-0001-9618-2299)
- Michael Betel
- Giada Sebastiani (ORCID: https://orcid.org/0000-0003-2655-8283)
- Cheryl Dale
- Jessica Burnside (ORCID: https://orcid.org/0009-0004-2515-5903)
- Supriya Joshi
Institutions
- The Graduate Center, CUNY (US)
- Western University (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Trillium Health Centre (CA)
- McGill University Health Centre (CA)
- Credit Valley Hospital (CA)
- University of Florida (US)
- Canadian Bio-Systems (Canada) (CA)
- Barcelona Institute for Global Health (ES)
- Canadian Association for the Study of the Liver (CA)
- Digital Research Alliance of Canada
Publication Details
- Journal
- Canadian Liver Journal
- Published
- 2025-11-01
- DOI
- https://doi.org/10.3138/canlivj-2025-0026
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00